Paul N Deslandes
Overview
Explore the profile of Paul N Deslandes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahmed S, Chaplin K, Young R, Deslandes P
Hum Psychopharmacol
. 2024 Nov;
39(6):e2912.
PMID: 39511954
Objective: This study investigated prescribing patterns of two cohorts of patients treated with selective serotonin reuptake inhibitors (SSRI) in primary care in Wales (UK), to better understand drivers for increased...
2.
Chaplin K, Bracchi R, Haines K, Routledge P, Deslandes P
Br J Clin Pharmacol
. 2023 Jul;
89(12):3596-3605.
PMID: 37403465
Aims: Limiting use of the antidepressant dosulepin has been encouraged due to associated risks of toxicity. In April 2011, the All Wales Medicines Strategy Group introduced a National Prescribing Indicator...
3.
Deslandes P, Bracchi R, Jones K, Haines K, Carey E, Adams A, et al.
Br J Clin Pharmacol
. 2022 Mar;
88(8):3829-3836.
PMID: 35322450
Aims: This study aimed to assess the impact of a National Reporting Indicator (NRI) on rates of reporting of suspected adverse drug reactions using the Yellow Card scheme following the...
4.
Keeping S, Deslandes P, Haines K, Routledge P
Pharmacoecon Open
. 2019 Jan;
3(3):343-350.
PMID: 30656545
Objectives: The All Wales Medicines Strategy Group (AWMSG) appraises the clinical and cost effectiveness of new medicines being considered for National Health Service (NHS) prescribing in Wales (UK). The aim...
5.
Deslandes R, John D, Deslandes P
Pharm Pract (Granada)
. 2015 Jul;
13(2):553.
PMID: 26131043
Background: Management of chronic disease has become an increasing challenge to the National Health Service in the United Kingdom. The introduction of supplementary prescribing was seen as a possible mechanism...
6.
Deslandes P, Thomas A, Faulconbridge G, Davies W
Int J Psychiatry Clin Pract
. 2014 Jun;
11(3):207-11.
PMID: 24941359
Typical antipsychotics are effective in the management of schizophrenia, but are associated with troublesome adverse effects which may lead to treatment discontinuation and relapse. Long-acting depot formulations of these drugs...
7.
Deslandes P, Thomas A, Blackmore E, Sewell R
Int J Psychiatry Clin Pract
. 2014 Jun;
12(4):243-6.
PMID: 24937709
Aim. The efficacy of aripiprazole has been demonstrated in randomised controlled trials, but due to inclusion and exclusion criteria, these may not be representative of clinical practice. The aim of...
8.
Deslandes P, Lewis A, Thomas A, Sewell R
Int J Psychiatry Clin Pract
. 2014 Jun;
13(4):298-302.
PMID: 24916940
Objective. The aim of this retrospective study was to assess the clinical effectiveness of risperidone long acting injection (RLAI) at 2 years within an acute mental health setting. Method. All...
9.
Deslandes P, Pache D, Buckland P, Sewell R
Eur J Pharmacol
. 2002 Oct;
453(2-3):223-9.
PMID: 12398908
Positive motivational properties of opioids, stimulants and serotonin selective reuptake inhibitors have been reported following place preference conditioning. The possibility that these effects are associated with changes in dopamine concentration...